{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:18:26Z","timestamp":1790687906358,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.berh.2010.01.008","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:38:42Z","timestamp":1282466322000},"page":"565-574","source":"Crossref","is-referenced-by-count":34,"title":["Stem cells in the treatment of inflammatory arthritis"],"prefix":"10.1016","volume":"24","author":[{"given":"Alan","family":"Tyndall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2010.01.008_bib1","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1186\/ar2848","article-title":"ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature","volume":"11","author":"Alivernini","year":"2009","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2010.01.008_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2010.01.008_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.beha.2004.04.003","article-title":"Stem cell transplantation for autoimmune disorders. Preclinical experiments","volume":"17","author":"van Bekkum","year":"2004","journal-title":"Best Practice & Research. Clinical Haematology"},{"key":"10.1016\/j.berh.2010.01.008_bib4","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2004-09-3715","article-title":"Control of systemic B-cell mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation","volume":"105","author":"Flierman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.berh.2010.01.008_bib5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/art.1780401017","article-title":"A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis","volume":"40","author":"McGonagle","year":"1997","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/ard.2004.033332","article-title":"Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration","volume":"64","author":"Verburg","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2010.01.008_bib7","first-page":"21","article-title":"Autologous stem cell transplantation for rheumatoid arthritis\u2013interim report of 6 patients","volume":"64","author":"Bingham","year":"2001","journal-title":"The Journal of Rheumatology. Supplement"},{"key":"10.1016\/j.berh.2010.01.008_bib8","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.21219","article-title":"Long-term follow-up of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation","volume":"52","author":"Teng","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/art.20859","article-title":"Reduction of joint damage in severe rheumatoid arthritis by high-dose chemotherapy and autologous stem cell transplantation","volume":"52","author":"Verburg","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib10","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2010.01.008_bib11","article-title":"Autologous hematopoietic stem cell transplantation (HSCT) for autoimmune diseases: an observational study on 12 years of experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases","author":"Farge","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.berh.2010.01.008_bib12","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/art.10495","article-title":"A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis","volume":"46","author":"Moore","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bmt.1704570","article-title":"A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation","volume":"34","author":"Moore","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.berh.2010.01.008_bib14","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2010.01.008_bib15","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.molimm.2008.12.029","article-title":"Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000\u20132007)","volume":"47","author":"Abinun","year":"2009","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.berh.2010.01.008_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/bmt.2008.171","article-title":"Exercise tolerance in children with juvenile idiopathic arthritis after autologous SCT","volume":"42","author":"Takken","year":"2008","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.berh.2010.01.008_bib18","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T-cells and restoring the CD4+CD25+ immune regulatory network","author":"de Kleer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.berh.2010.01.008_bib19","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1182\/blood-2007-12-128488","article-title":"Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells","volume":"111","author":"Roord","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.berh.2010.01.008_bib20","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/ar2309","article-title":"Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study","volume":"9","author":"Teng","year":"2007","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2010.01.008_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/art.10186","article-title":"Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis","volume":"46","author":"Brinkman","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.10093","article-title":"High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis","volume":"46","author":"Bingham","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib23","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar1452","article-title":"Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia","volume":"7","author":"Ponchel","year":"2005","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2010.01.008_bib24","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1182\/blood-2002-03-0671","article-title":"Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis","volume":"100","author":"Ponchel","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.berh.2010.01.008_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.berh.2010.01.008_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/bmt.2009.63","article-title":"Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks","volume":"43","author":"Tyndall","year":"2009","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.berh.2010.01.008_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.berh.2010.01.008_bib28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21012","article-title":"Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis","volume":"52","author":"Djouad","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.22511","article-title":"Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis","volume":"56","author":"Augello","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2249.2008.03683.x","article-title":"Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice","volume":"153","author":"Choi","year":"2008","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.berh.2010.01.008_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.berh.2010.01.008_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","article-title":"Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro","volume":"46","author":"Bocelli-Tyndall","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2010.01.008_bib33","article-title":"Human adipose-derived mesenchymal stem cells reduce inflammatory and T-cell responses and induce regulatory T cells in vitro in rheumatoid arthritis","author":"Gonzalez-Rey","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2010.01.008_bib34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2010.01.008_bib35","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garcia-Olmo","year":"2005","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.berh.2010.01.008_bib36","first-page":"50","article-title":"Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study","volume":"4","author":"Mohyeddin Bonab","year":"2007","journal-title":"Iranian Journal of Immunology"},{"key":"10.1016\/j.berh.2010.01.008_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-7-29","article-title":"Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis","volume":"7","author":"Riordan","year":"2009","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.berh.2010.01.008_bib38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1352458509104590","article-title":"Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis","volume":"15","author":"Liang","year":"2009","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.berh.2010.01.008_bib39","first-page":"459","article-title":"Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis","volume":"10","author":"Mohamadnejad","year":"2007","journal-title":"Archives of Iranian Medicine"},{"key":"10.1016\/j.berh.2010.01.008_bib40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.berh.2010.01.008_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000156223","article-title":"Cell therapy for age-related disorders: myocardial infarction and stroke\u2013a mini-review","volume":"54","author":"Williams","year":"2008","journal-title":"Gerontology"},{"key":"10.1016\/j.berh.2010.01.008_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/ard.2007.071233","article-title":"Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis","volume":"67","author":"Larghero","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2010.01.008_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/art.10126","article-title":"Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis","volume":"46","author":"Marinova-Mutafchieva","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.008_bib44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/rheumatology\/38.9.854","article-title":"Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis","volume":"38","author":"Tomita","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2010.01.008_bib45","article-title":"Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level","author":"Jones","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2010.01.008_bib46","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694210000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694210000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T16:57:32Z","timestamp":1544288252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694210000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1521694210000094"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2010.01.008","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}